Weebit Nano Ltd (ASX: WBT) shares are back in the green on Tuesday, extending what has already been one of the ASX’s standout 12-month performances.

In morning trade, the Weebit Nano share price is up 2.54% to $3.64.

The latest gain adds to a remarkable rally that has seen the stock surge almost 150% over the past year, driven by growing confidence in its ReRAM memory technology and broader AI commercial opportunity.

With momentum still on its side, today’s rise suggests investors see further upside in the company’s next growth phase.

Retail investors get access after $80 million raise

Today’s update is the next stage of the recent capital raising, when Weebit Nano launched an $80 million institutional placement alongside an Israeli placement targeting up to $10 million.

The funds are intended to strengthen the balance sheet and support a faster push into next-generation memory and AI in-memory compute applications.

The newly opened SPP is targeting up to another $15 million, though management can accept additional demand or scale applications back.

The offer opened today and is scheduled to close on 29 April, with the new shares expected to be allotted on 6 May.

For existing shareholders, the SPP offers access at the same $4.05 price paid by institutions, without brokerage costs.

That said, with the stock trading at $3.64 this morning, the market is pricing the shares below the offer price. This could reduce short-term retail demand unless investors are looking further ahead to potential licensing growth.

Why investors are still interested

The bigger driver behind the strong 12-month share price performance is Weebit Nano’s licensing momentum.

The company’s ReRAM technology is being positioned as a lower-power replacement for embedded flash memory across AI, IoT, automotive, industrial automation, and edge computing devices.

Recent commercial wins, including its licensing agreement with Texas Instruments, have strengthened confidence that the technology is moving from early validation into broader commercial use.

With a market capitalisation of about $840 million, the stock remains one of the ASX tech sector’s biggest winners over the past 12 months.

Investors appear willing to look past the short-term dilution from the raise and stay focused on growth in AI memory markets.

Foolish takeaway

Tuesday’s gain suggests the market has responded well to Weebit Nano broadening its recent raise to include everyday retail shareholders.

The next focus will be SPP uptake and whether the fresh capital can help support additional foundry and semiconductor licensing deals in the year ahead.

The post This ASX tech stock is up 150% in a year. Here’s why it’s climbing again today appeared first on The Motley Fool Australia.

More reading

• Why DroneShield, Hub24, Syrah, and Weebit Nano shares are sinking today
• Why are Weebit Nano shares crashing 15% today?
• This ASX tech stock is frozen today. Here’s what’s going on
• 4 ASX tech shares tipped to jump up to 140% higher

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The ASX bank share space could be an appealing place to invest during the rising interest rate environment. Owning National Australia Bank Ltd (ASX: NAB) shares is one of the options to consider for dividends.

The bank may benefit from the Reserve Bank of Australia (RBA) increasing the cash rate because NAB can lend out transaction account balances for a higher return (but the cost is minimal and doesn’t change, unlike a savings account balance, during rate hikes).

But, there is a danger of higher loan arrears and bad debts due to rate rises, which may be a headwind for NAB’s profit. Let’s have a look at what could happen with the dividend in the coming years.

FY26

The bank recently reported its FY26 first quarter which included some strong positives.

It said it generated $2.02 billion of cash earnings, representing a 16% increase year-over-year. The bank said that underlying net profit grew by 12% year-over-year.

The bank said it was executing across key priorities including growing business banking, driving deposit growth and strengthening its own-channel (proprietary) home lending.

Australian business lending rose 2%, with market share gains in small and medium enterprises (SMEs) and total business lending.

Its Australian home lending grew by 1.1x the speed of the overall lending system, implying that it grew market share.

NAB also noted that its deposit balances in business and private banking and personal banking, increased 3%, including 6% growth in transaction accounts excluding offsets.

The ASX bank share is also targeting productivity savings of more than $450 million for FY26 and it’s also aiming for FY26 operating expense growth to be less than FY25 growth of 4.6%.

In terms of the dividend for owners of NAB shares, the projection on CMC Invest suggests that the ASX bank share could pay an annual payout of $1.705 in FY26. At the time of writing, that’s a dividend yield of 4.1%, or 5.8% including franking credits.

FY27

Time will tell what happens with the Middle East, fuel prices, inflation and interest rates, but I wouldn’t be surprised if we’re still living with the effects of it in the 2027 financial year.

Currently, analysts are projecting an increase in the NAB dividend in the 2027 financial year. In this period of uncertainty. If I were a shareholder, I’d be happy with any sort of dividend growth during economic challenges.

The projection on CMC Invest suggests that NAB could hike its annual dividend per share by 1.5% to $1.73.

FY28

The final year of this series of projections is the 2028 financial year, which could see another year of growth for the dividend.

Currently, the forecast on CMC Invest suggests the annual payout could grow another 1.7% year-over-year to $1.76 per share.

That’s certainly not the strongest growth rate around for dividend rises, but it’s a lot better than nothing and would ensure a pleasing ongoing dividend yield for investors.

The post Here’s the dividend forecast out to 2028 for NAB shares appeared first on The Motley Fool Australia.

More reading

• What happened with ASX 200 bank stocks like CBA and Westpac in March?
• How many NAB shares do I need to buy for $10,000 a year in passive income?
• Which ASX bank has the biggest dividend yield?
• Why NAB shares are slipping today despite a major business reset
• Buy, hold, sell: NAB, Pro Medicus, and Telstra shares

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

If you are looking for exposure to the mining sector this week, then it could be worth hearing what the team at Fairmont Equities is recommending, courtesy of The Bull.

Let’s see what the equities firm is recommending to Aussie investors:

Betashares Global Uranium ETF (ASX: URNM)

The first ASX mining share that Fairmont Equities is tipping as a buy this week is actually an exchange traded fund (ETF).

The Betashares Global Uranium ETF provides investors with exposure to leading global stocks that are involved in the mining, exploration, development, and production of uranium, modern nuclear energy, or that hold physical uranium or uranium royalties.

Fairmont Equities thinks it would be a good option for investors given its positive view on the outlook for uranium. This is especially the case given a recent pullback in the ETF’s unit price.

Commenting on the ETF, the equities firm said:

I remain positive about the outlook for the uranium sector. URNM provides exposure to a portfolio of mining, exploration and development companies in the global uranium industry. URNM stock rose from $6.34 on April 3, 2025 to $15.24 on January 29, 2026.

The stock was trading at $12.31 on April 2, 2026. The recent dip provides investors with another buying opportunity. We expect demand for uranium to exceed supply in the years ahead, particularly as countries diversify their energy sources away from fossil fuels.

New Hope Corporation Ltd (ASX: NHC)

Another ASX mining share that could be a buy according to Fairmont Equities is coal miner New Hope.

The equities firm believes that demand for coal will remain strong, especially given the war in the Middle East. As a result, it thinks that New Hope is well-positioned to profit from this strong demand.

It also highlights that recent trading patterns are favourable, which it thinks points to significant upside potential.

Commenting on the mining share, Fairmont Equities said:

I have been bullish on this thermal coal producer for several months. I believe global demand for coal will remain elevated. The conflict in the Middle East is lifting demand for thermal coal, with countries, such as Japan, increasing coal-fired power generation to offset instability in gas markets. During the past few weeks, NHC shares broke out of a bullish technical pattern on strong volume, which implies significant upside from here.

The post 2 ASX mining shares to buy: Expert appeared first on The Motley Fool Australia.

More reading

• Why are shares in this uranium company surging today?
• 3 ASX ETFs to buy before the rally really takes off: expert
• These were the best-performing ASX 200 shares in March
• Why 4DMedical, New Hope, Santos, and St George Mining shares are dropping today
• 5 things to watch on the ASX 200 on Tuesday

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

BHP Group Ltd (ASX: BHP) shares are charging higher today.

Shares in the S&P/ASX 200 Index (ASX: XJO) mining giant closed on Thursday trading for $51.23. In morning trade on Tuesday, shares are changing hands for $52.92 apiece, up 3.3%.

That sees the share price up an impressive 53.1% over the past 12 months. And that’s not including the $1.958 in fully-franked dividends BHP paid out over the full year. If we add those back in, then the accumulated value of BHP shares has surged 58.8% since 7 April 2025.

Atop its own operational successes, the miner has enjoyed a resilient iron ore price. The industrial metal is trading at around US$107 per tonne today, up from US$99 per tonne a year ago.

Then there’s copper. At US$12,360 per tonne, the copper price is up 42% since this time last year.

Which brings us back to our headline question…

Are BHP shares still a good buy now?

For a deeper dive into this million-dollar question, we defer to three investing experts who ran their slide rules over the mining giant late last week (courtesy of The Bull).

“The commodities bull market has only just started, in my view,” said Fairmont Equities’ Michael Gable.

“As a global mining giant, BHP generally appeals to investors looking to increase exposure in the resources sector,” he added.

And Gable noted that BHP shares remain down 12% since closing at $59.25 on 2 March.

Summing up his hold recommendation on the ASX 200 mining stock he said:

BHP’s share price has retreated to a major support level since the start of the war in Iran. I’m confident the stock should bounce from these levels. BHP’s diversification makes it a safer bet for investors to ride the commodities bull market.

Morgans Financial’s Mitch Belichovski also has a current hold recommendation on BHP shares.

“BHP is a diversified mining company producing iron ore, copper, nickel, metallurgical coal and potash,” he said.

Belichovski added:

First half revenue in fiscal year 2026 grew 11% on the prior corresponding period and profit after tax was up 28%. The fully franked interim dividend of US73 cents a share was up 46% and ahead of consensus.

BHP’s fundamentals position it to play a recovery in China’s subdued growth. Capital expenditure cycles and copper growth provide a compelling reason to retain BHP as a core position in portfolios.

And another hold…

Also issuing a hold recommendation on BHP shares this week is Investor Pulse’s Mark Elzayed.

“The company remains a global resources powerhouse, increasingly focused on future-facing commodities, such as copper and potash,” he said. “The first half result in fiscal year 2026 highlights a robust performance across its portfolio.”

Elzayed sounded particularly bullish on BHP’s increasing copper production. He noted:

Iron ore continues to deliver strong cash flow, but copper has become the standout performer, contributing about 51% of total earnings. Copper production guidance has been upgraded to between 1.9 million tonnes and 2 million tonnes following record output at its Escondida operation and various South Australian assets.

Elzayed concluded:

Valuation metrics indicate that BHP was recently trading in line with historical enterprise value-to-earnings multiples, reflecting solid fundamentals and current commodity price expectations.

The post Up 59% in a year, should you still buy BHP shares today? appeared first on The Motley Fool Australia.

More reading

• Why I think BHP, CBA, and DroneShield shares are buys in April
• BHP shares just dropped — is this your chance to buy the dip?
• Buy, hold, sell: Aristocrat, BHP, and Woodside shares 
• Why now could be the time to buy these popular ASX ETFs
• How did these ASX blue-chip shares perform in March?

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Fortescue Ltd (ASX: FMG) shares are trading in the green on Tuesday morning. At the time of writing, the shares are up 1.7% to $20.60 a piece.

The latest uptick means the shares have now climbed 8.3% over the past month, although they’re still down 7% for the year to date.

For the year, the shares are 43.7% higher. 

It’s been a volatile start to the year for Fortescue shares, so if you’re thinking of adding the stock to your portfolio, here are some things to consider. 

3 reasons to buy Fortescue shares

1. Attractive dividend yield

Because the miner is a low-cost producer, meaning it can remain profitable even when iron ore falls, it is able to pay a reliable dividend to investors. Fortescue is a popular high-yielding dividend-paying stock. Broker UBS predicts that Fortescue could pay an annual dividend per share of $1.22. At the time of writing, that translates into a grossed-up dividend yield of just over 5.92%, including franking credits.

2. Copper exposure

Fortescue is primarily an iron ore miner but it is actively expanding in the copper space. Not only will that give the miner more diversity and less reliance on the iron ore market, it could also give long-term operational upside. If its copper exposure keeps growing it would help support overall earnings.

3. Expansion and growth

Fortescue is continually investing in business expansion. Not only is the miner planning to grow its copper exposure, it is also focused on building significant renewable energy infrastructure, decarbonisation and expansion of its green energy projects, and developing and expanding its existing iron ore sites to improve production efficiency. These projects are positive for long-term profitability.

3 reasons to sell Fortescue shares

1. Heavily tied to iron ore prices

While Fortescue has a copper footprint, the miner primarily mines and exports iron ore. This means it is heavily reliant on the price of iron ore and is subject to any price fluctuations that the material might have. The price of iron ore is expected to soften through 2026 and then gradually decline through to 2030 as supply increases and Chinese steel demand tapers off.

2. The shares are overpriced

Fortescue’s share price is looking overvalued right now. While its current price-to-earnings (P/E) ratio of 11.54 looks attractive on the surface (the average P/E ratio within ASX metals and mining companies is anywhere between 12.5 and 25), it doesn’t take into account projected declines in earnings. UBS forecasts that the business will earn US$3.8 billion in net profit in FY26, but this is expected to drop to US$2.94 billion in FY27 off the back of lower iron ore prices.

3. Brokers rate the stock as a sell

Analysts are mostly bearish on Fortescue shares. TradingView data shows that nine out of 17 analysts have a hold rating on the stock, and another seven have a sell or strong sell rating. The average 12-month target price of $20.02 implies a potential 1.1% downside at the time of writing.

The post Fortescue shares: 3 reasons to buy and 3 reasons to sell appeared first on The Motley Fool Australia.

More reading

• Buying ASX 200 mining shares? Here’s how Rio Tinto, Fortescue and BHP stacked up in March
• ASX 200 mining shares ride a rollercoaster in March quarter
• 3 reasons why this could be a great time to buy Fortescue shares!
• ASX 200 mining shares rebound after March sell-off creates opportunities
• Is this ASX iron ore stock a better buy than Fortescue?

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Telix Pharmaceuticals Ltd (ASX: TLX) shares are on the move on Tuesday morning.

At the time of writing, the radiopharmaceuticals company’s shares are up 8.5% to $14.05.

Why are Telix shares rising today?

Investors have been buying Telix shares following the release of a quarterly update highlighting strong revenue growth and progress across its therapeutics pipeline.

According to the release, Telix reported unaudited group revenue of US$230 million for the first quarter of FY 2026, representing a 24% increase on the prior corresponding period and an 11% lift on the previous quarter.

Its Precision Medicine division was a key driver, delivering US$186 million in revenue, up 23% year on year and 16% quarter on quarter. This was supported by strong demand for its imaging products Illuccix and Gozellix.

Guidance reaffirmed

In addition to the strong quarterly performance, Telix has reaffirmed its full year revenue guidance.

The company continues to expect FY 2026 revenue in the range of US$950 million to US$970 million, reflecting confidence in ongoing growth across its commercial operations.

Management highlighted that this outlook is underpinned by continued expansion of its global footprint and increasing adoption of its products.

Pipeline progress continues

Telix also provided an update on its therapeutics pipeline, highlighting progress across multiple late-stage programs.

Notably, its TLX591-Tx prostate cancer therapy candidate met safety and dosimetry objectives in a Phase 3 study, with no new safety signals observed.

The company also continues to advance other clinical programs, including trials targeting kidney cancer and glioblastoma, as well as expanding patient recruitment across multiple regions.

In addition, Telix is progressing regulatory submissions, including the resubmission of its New Drug Application to the US Food and Drug Administration for its brain cancer imaging candidate TLX101-Px.

Management commentary

Telix’s managing director and CEO, Dr Christian Behrenbruch, was pleased with the quarter and appears positive on its outlook. He said:

Growth accelerated across our Precision Medicine business in the first quarter, with U.S. dose volumes increasing 5% quarter-over-quarter. This performance reflects the growing uptake of Gozellix alongside Illuccix, contributing to market share gains underpinned by disciplined sales execution and pricing, and high-quality service delivery despite extreme North American weather conditions, an advantage of the pharmacy distribution model.

With our two-product PSMA imaging strategy, differentiated clinical positioning and expanding commercial presence globally, we are seeing a solid foundation for continued growth through 2026. Importantly, we are delivering on our strategic priorities to advance our high-value clinical programs, demonstrated by the momentum in our therapeutics pipeline this quarter.

The post Why are Telix shares jumping 8% today? appeared first on The Motley Fool Australia.

More reading

• Telix Pharmaceuticals Q1 2026: Revenue growth, guidance reaffirmed
• These are the 10 most shorted ASX shares
• 3 ASX 200 healthcare shares to buy amid sector rout
• 3 reasons to buy this red-hot ASX healthcare stock today
• These were the best-performing ASX 200 shares in March

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Mesoblast Ltd (ASX: MSB) share price is in focus after the company reported Ryoncil® net sales of US$30.3 million for the March 2026 quarter, bringing total net revenue since launch to nearly US$100 million.

What did Mesoblast report?

• Net sales for Ryoncil® reached US$30.3 million in the third quarter to March 2026
• Revenue since Ryoncil® launch now approaches US$100 million
• Strong sales growth in February and March offset a seasonal dip in January
• Ryoncil® is the only FDA-approved cell therapy for children under 12 with steroid-refractory acute graft-versus-host disease (SR-aGvHD)

What else do investors need to know?

Mesoblast’s first year of Ryoncil® sales has boosted its balance sheet and is helping to fund label extensions and late-stage clinical programs. The company reiterated its leadership role by being first to market with an FDA-approved mesenchymal stromal cell therapy.

Mesoblast will host its first R&D Day in New York on 8 April 2026, where it will outline growth strategies for Ryoncil® and provide updates on its late-stage product pipeline. Investors can join the live webcast or access a replay on the company’s website.

What’s next for Mesoblast?

The company is focusing on expanding Ryoncil®’s approved uses, including studies in adults with SR-aGvHD and in biologic-resistant inflammatory bowel disease. Mesoblast is also progressing clinical development of rexlemestrocel-L for heart failure and chronic low back pain.

Ongoing investment in its product pipeline and global partnerships should ensure Mesoblast stays at the cutting edge of cell therapy for major inflammatory diseases.

Mesoblast share price snapshot

Over the past 12 months, Mesoblast shares have risen 29%, outperforming the S&P/ASX 200 Index (ASX: XJO), which has risen 20% over the same period.

View Original Announcement

The post Mesoblast shares: Ryoncil® underpins strong earnings growth appeared first on The Motley Fool Australia.

More reading

• Capricorn Metals delivers solid Q3 FY26 gold production and growth update
• Summerset Group Q1 2026 sales rise on robust demand
• Ramelius Resources confirms guidance, strong March quarter gold output
• Bank of Queensland announces $3.7bn loan sale and capital partnership with Challenger
• Guzman y Gomez posts 20% Q3 FY26 sales growth

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

Shares in Cauldron Energy Ltd (ASX: CXU) are trading strongly today after the company announced it has been included in the BetaShares Global Uranium ETF (ASX: URNM).

Cauldron said in a statement to the ASX on Tuesday morning that public disclosures showed that Betashares currently holds 15.8 million Cauldron shares worth $678,352.

Major endorsement

Cauldron said that inclusion in the exchange traded fund was an important milestone for the company, “reflecting the Company’s growing relevance within the global uranium sector”.

The company went on to say:

Moreover, the company considers ETF inclusion extremely positive as it will likely enhance global investor awareness of Cauldron, broaden access to institutional and passive capital flows, support liquidity and trading volumes over time; and reinforce Cauldron’s exposure to the nuclear energy thematic, which is experiencing strong global momentum.

Cauldron Energy chief executive officer Jonathan Fisher added:

Inclusion in the BetaShares Global Uranium ETF is a strong endorsement of Cauldron’s progress and positioning within the uranium sector. As global capital continues to flow into nuclear energy and uranium equities, inclusion in a leading ETF such as URNM enhances our visibility to a broader investor base and supports our ongoing growth strategy.

Strong returns

The URNM ETF, according to its website, has returned 89.64% over the year to the end of March, and 26.47% per annum over five years.

The ETF says this regarding its objectives:

Nuclear energy is increasingly being accepted as a safe, reliable, low-carbon energy source and seen as a critical supplementary means of meeting the world’s growing energy demands. As a result, demand for uranium to fuel nuclear power stations is projected to grow strongly. URNM provides exposure to leading global companies involved in the mining, exploration, development and production of uranium, modern nuclear energy, or that hold physical uranium or uranium royalties.

The ETF is currently valued at $325.6 million.

The ETF holds a range of international and Australian companies, including Nac Kazatomprom and Cameco Corp internationally, and Paladin Energy Ltd (ASX: PDN), NexGen Energy Ltd (ASX: NXG) and Deep Yellow Ltd (ASX: DYL) locally.

Cauldron Energy shares were trading 11.6% higher in early trade at 4.8 cents. The company was valued at $88 million at the close of trade on Thursday.

Cauldron recently updated its mineral resource at its flagship Yanrey project in Western Australia, where it increased the resource by 13.67 million pounds of uranium oxide to more than 55 million pounds.

The company is expecting to start its 2026 drilling program in May, with “many high priority targets”.

The post Why are shares in this uranium company surging today? appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• These were the worst-performing ASX 200 shares in March
• Why is this ASX energy stock racing 7% higher today?
• Paladin Energy shares: Judicial review challenges EIS approval
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The S&P/ASX 200 Index (ASX: XJO) is up 1.6% in early morning trade on Tuesday, with two ASX 200 gold stocks helping boost the benchmark index.

Ramelius Resources Ltd (ASX: RMS) shares are tracking the benchmark gains, up 1.6% at time of writing at $3.74 apiece.

Capricorn Metals Ltd (ASX: CMM) shares are enjoying an even stronger run, up 4.9% at $11.48 each.

This follows the release of preliminary March quarterly updates from both Aussie gold miners.

Here’s what we know.

Ramelius Resources shares lift on guidance outlook

Starting with Ramelius, the ASX 200 gold stock is marching higher after releasing its preliminary March quarter production update.

The miner reported gold production of 38,093 ounces for the three months, down more than 52% from the 80,455 ounces produced in the prior corresponding quarter.

Ramelius said the big decline in the quarterly production was caused in part by heavy rainfall from Cyclone Narelle. On the positive side, this has left the miner with significant high-grade mine stockpiles at the end of the quarter.

Management also said that operations have not been impacted to date by diesel supply chain disruptions.

And despite the March decline, the ASX 200 gold stock said it remains on track to achieve the midpoint of its full year FY 2026 production guidance of 185,000 to 205,000 ounces of gold, forecasting a strong June quarter.

As at 31 March, Ramelius Resources had a cash and gold balance of $606.5 million.

Commenting on the results, Ramelius Resources managing director Mark Zeptner said:

Ramelius remains committed to maintaining and growing shareholder returns. With $110 million in share buybacks during the quarter, we are executing on another element of our plan to deliver value to shareholders.

ASX 200 gold stock lifts on another strong quarter

Turning to Capricorn Metals, investors are bidding up the gold miner after the company reported producing 30,358 ounces of gold in the March quarter from its Karlawinda Gold Project (KGP). That’s broadly in line with the 30,599 ounces of gold produced in the prior corresponding quarter.

Management said that KGP has now produced 93,152 ounces of gold over the first three quarters of FY 2026. This positions the ASX 200 gold stock to achieve the upper end of its full year production guidance of 115,000 ounces to 125,000 ounces of gold.

Capricorn Metals expects to produce that gold at an all-in sustaining cost (AISC) of $1,530 to $1,630 per ounce.

Capricorn said it is also not currently impacted by any diesel fuel supply issues. But the miner noted that this remains a material risk across the Australian mining industry.

At the end of the quarter, the miner had a cash and gold balance of $507.6 million.

The post 2 ASX 200 gold stocks jumping higher on major updates today appeared first on The Motley Fool Australia.

More reading

• Capricorn Metals delivers solid Q3 FY26 gold production and growth update
• Ramelius Resources confirms guidance, strong March quarter gold output
• 5 things to watch on the ASX 200 on Tuesday
• ASX gold shares tumble as bull run faces its first big test in 1Q CY26
• These 3 dirt-cheap ASX shares are tipped to climb another 50-90%

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Core Lithium Ltd (ASX: CXO) shares are pushing higher on Tuesday after the company announced another major operational milestone.

In early trade, the Core Lithium share price is up 5.88% to 27 cents.

The gain comes after the lithium miner confirmed that open pit mining at its Grants deposit will begin immediately, marking the first stage of the Finniss Lithium Project restart.

Core Lithium remains one of the ASX’s strongest recovery stories, with its share price still up 347% over the past 12 months.

The positive move suggests investors are continuing to back the Finniss restart timeline as the company shifts from planning into execution.

Mining restart moves from plan to execution

According to the release, Core Lithium has awarded the surface mining contract for the Grants open pit to NRW Pty Ltd.

Mobilisation is set to begin immediately.

The contract covers all key mining activities required to deliver ore to the Grants run-of-mine pad.

Management said this is a key first step in the restart of mining operations at Finniss following last month’s final investment decision (FID).

The company expects the optimised Grants pit design to provide access to about 784kt of ore, which is forecast to produce roughly 134kt of SC6 spodumene concentrate over a short timeframe.

Ore from Grants is scheduled to be processed and hauled during the September quarter. First spodumene concentrate shipments are targeted for early in the December quarter.

This near-term production profile may be appealing to investors because it gives Core Lithium a pathway back to revenue using existing infrastructure and relatively low upfront capital.

Why the market is backing the Finniss restart

While the update supports the Finniss restart, today’s share price gain suggests investors are responding positively to the move into active mining works.

The company approved the Finniss restart less than 3 weeks ago. That decision followed a funding package of more than $300 million across debt, equity, and strategic support.

With funding secured, investors now turn to whether Core Lithium can meet production and shipment targets through the second-half of 2026.

Execution remains the next key focus, with mobilisation, processing readiness, and lithium pricing all likely to influence whether the rally can continue.

Foolish takeaway

Today’s announcement moves Core Lithium another step closer to turning its Finniss restart strategy into cash flow.

After a 347% gain over the past year, today’s rise suggests investors remain confident in the company’s near-term production pathway.

The next major catalyst is likely to be first ore movement and confirmation that September quarter processing remains on schedule.

The post Why this ASX lithium stock is charging higher after a major breakthrough appeared first on The Motley Fool Australia.

More reading

• ASX 200 mining shares rebound after March sell-off creates opportunities
• Why A2 Milk, BWP, Core Lithium, and Newmont shares are sinking today
• Core Lithium shares tumble after $120m capital raising for Finniss restart
• 5 things to watch on the ASX 200 on Thursday
• Why this ASX lithium stock requested a trading halt today

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.